Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2
Authors:
- M. Dolores SalvadoMSM. Dolores Salvado
- Arántzazu AlfrancaAAArántzazu Alfranca
- Jesper Z. HaeggströmJHJesper Z. Haeggström
- Juan Miguel RedondoJRJuan Miguel Redondo
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 18 (4) , 233-243
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasisBiochemical Journal, 2009
- The EP1 subtype of prostaglandin E2 receptor: Role in keratinocyte differentiation and expression in non-melanoma skin cancerProstaglandins, Leukotrienes and Essential Fatty Acids, 2009
- PGF2α stimulates FP prostanoid receptor mediated crosstalk between Ras/Raf signaling and Tcf transcriptional activationBiochemical and Biophysical Research Communications, 2009
- Role of prostaglandin D 2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivoProceedings of the National Academy of Sciences, 2008
- Prostaglandin F2α stimulates motility and invasion in colorectal tumor cellsInternational Journal of Cancer, 2007
- Effects of 15d-PGJ2 on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cellsProstaglandins & Other Lipid Mediators, 2006